J&J Meeting With Wholesalers To Limit Forward Buying
Executive Summary
Johnson & Johnson is meeting with pharmaceutical distributors to attempt to reach an agreement to limit forward buying
You may also be interested in...
Bristol Inventory Issues Include High Supply Of Glucophage IR
Bristol-Myers Squibb's new approach to wholesaler inventory levels should help the company capture more of the benefit from product price increases, CEO Peter Dolan suggested during an April 25 earnings conference call
Bristol Inventory Issues Include High Supply Of Glucophage IR
Bristol-Myers Squibb's new approach to wholesaler inventory levels should help the company capture more of the benefit from product price increases, CEO Peter Dolan suggested during an April 25 earnings conference call
Cardinal Manufactures 10% Gain In 1Q: Rx Stocks Stay Out Of Favor
Cardinal's expanding manufacturing capacity is enhancing its image with investors who are attracted to the pharmaceutical sector but wary of the risks of drug development